SCHEMBL104521

SCHEMBL104521

CCCCCCCCCCCCCCCCC(N)=O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 2/20 0.74
MEN1 O00255 2/20 0.74
KMT2A Q03164 2/20 0.74
FAAH O00519 1/20 0.74
TP53 P04637 1/20 0.74
CYP1A2 P05177 1/20 0.74
CYP3A4 P08684 1/20 0.74
CYP2C19 P33261 1/20 0.74
KDM4E B2RXH2 2/20 0.65
CES2 O00748 3/20 0.65
CES1 P23141 3/20 0.65
GPR84 Q9NQS5 7/20 0.62
PPARG P37231 6/20 0.62
PPARD Q03181 6/20 0.62
PPARA Q07869 6/20 0.62
HDAC11 Q96DB2 5/20 0.62
TSHR P16473 4/20 0.62
ALDH1A1 P00352 2/20 0.62
TLR2 O60603 2/20 0.62
TDP1 Q9NUW8 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL216219 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL2048989 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
Hexane SCHEMBL9626247 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL218192 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL8743286 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL42192 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL6046254 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
Palmitamide SCHEMBL43384 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
Octadecanoic Acid Amide SCHEMBL8417300 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53
SCHEMBL22319678 1.00 SOAT1 (0.74) SOAT1MEN1KMT2AFAAHTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 577 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4537111-A2 MULTI-OMICS ASSESSMENT Prognomiq Inc (US) 2025-04-16 EP claimed
CN-119816897-A Multiple study assessment 普罗科技有限公司 2025-04-11 CN claimed
US-20240377729-A1 ORGANOTIN PHOTORESIST COMPOSITION AND METHOD OF STABILIZATION LU FENG (US) 2024-11-14 US claimed
WO-2024233871-A1 ORGANOTIN PHOTORESIST COMPOSITION AND METHOD OF STABILIZATION LU FENG (US) 2024-11-14 WO claimed
WO-2023240046-A2 MULTI-OMICS ASSESSMENT PrognomIQ, Inc. (US) 2023-12-14 WO claimed
CN-115011402-B Low-viscosity energy-saving diesel engine oil based on cerium oxide nano additive and preparation method thereof 河南大学 2023-02-03 CN claimed
CN-115011402-A Low-viscosity energy-saving diesel engine oil based on cerium oxide nano additive and preparation method thereof 河南大学 2022-09-06 CN claimed
CN-114002421-B Application of exosome metabolite as bipolar affective disorder marker 佛山市第三人民医院(佛山市精神卫生中心) 2022-04-05 CN claimed
CN-114002421-A Application of exosome metabolite as bipolar affective disorder marker 佛山市第三人民医院(佛山市精神卫生中心) 2022-02-01 CN claimed
CN-112855003-A Magnetic soft screen door made of high polymer material 利辛县雨若信息科技有限公司 2021-05-28 CN claimed
CN-101322494-A Pesticide composition and preparation and use method thereof JIANGSU BOTAM BOXMORE PACKAGIN (CN) 2008-12-17 CN claimed
WO-2008147228-A1 TREATMENT OR PREVENTION OF BONE CONDITIONS FONTERRA CORPORATE RESEARCH AND DEVELOPMENT LIMITED (NZ) 2008-12-04 WO claimed
WO-2008125805-A1 METABOLIC PROFILING OF FATTY ACID AMIDES AND ITS USE IN THE DIAGNOSIS OF AND SCREENING OF DRUGS FOR SCHIZOPHRENIA CAMBRIDGE ENTERPRISE LIMITED (GB) 2008-10-23 WO claimed
US-20070027234-A1 Cellulosic-thermoplastic composite and method of making the same ADDIVANT USA, LLC 2007-02-01 US claimed
EP-0781801-B1 Silica-filled rubber compositions containing dialkyleneamide polysulfides GOODYEAR TIRE & RUBBER (US) 1999-09-15 EP claimed
US-5080999-A Light-sensitive diazo resin composition containing a higher fatty acid or higher fatty acid amide FUJI PHOTO FILM CO., LTD. (JP) 1992-01-14 US claimed
EP-0107850-B1 AMINOGLYCOSIDE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-04-06 EP claimed
US-4493831-A ANTIBIOTICS, VIRICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-01-15 US claimed
EP-0107850-A1 Aminoglycoside derivatives, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-05-09 EP claimed
US-3954460-A Method of sinter coating metal strips with metallic powder using fatty acid amide as a temporary adhesive INLAND STEEL COMPANY (US) 1976-05-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240377729-A1 ORGANOTIN PHOTORESIST COMPOSITION AND METHOD OF STABILIZATION NCLN, NCL, RPS13 SOAT1 396/4885MEN1 3411/4885KMT2A 2202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.